Skip to main content
Live · TradingView
Back to the NewsWire

Medicaldaily

Published September 16, 2026 · Updated September 17, 2026

Heart Risks, Provider Misconduct, and a 21-Year-Old's Death Sharpen Safety Warnings as ...

Read the full story at Medicaldaily

On the day of the hearing, Definium Therapeutics announced a third positive phase 3 result for its LSD tablet and said it has an FDA meeting set.

Surfaced by 2 Google Alerts

  • LSD
  • Psychedelic biotech